A nonpathogenic strain of Citrobacter sedlakii which expresses the Escherichia coli O157 antigen is described. The discovery of this strain emphasizes the necessity of additional biochemical and/or toxigenicity testing when isolates react with E. coli O157 latex reagents.
with the GNI card (bioMérieux Vitek, Inc., Hazelwood, Mo.) identified the isolate as Enterobacter amnigenus, while the RadID onE system (Remel Atlanta [formerly Innovative Diagnostic Systems], Norcross, Ga.) and the Walk/Away Neg Combo X panel (Dade Microscan, Inc., West Sacramento, Calif.) identified it as Citrobacter amalonaticus. Because of this discrepancy, the isolate was submitted to the Centers for Disease Control and Prevention, Atlanta, Ga., where it was classified as C. sedlakii by using conventional biochemicals. C. sedlakii, one of the new genomospecies of Citrobacter formerly called C. freundii, has been isolated from human blood, wounds, and stool and was recently isolated from cerebrospinal fluid from a neonate (2, 3) . C. sedlakii is not currently in the databases of any of these three systems, but they should have rendered an identification of C. freundii. The C. freundii organism isolated by Sowers et al. (9) may have belonged to this new genomospecies of Citrobacter; however, this speculation has not been confirmed.
Conventional biochemical tests which yielded positive reactions included nitrate, indole production, citrate utilization, ornithine decarboxylase, arginine dihydrolase, o-nitrophenyl-␤-D-galactopyranoside (ONPG), malonate, and fermentation of glucose, dulcitol, lactose, melibiose, arabinose, and maltose. Negative reactions were obtained with tests for oxidase, lysine decarboxylase, H 2 S production, and fermentation of raffinose, sucrose, and ␣-methyl-D-glucoside. C. sedlakii can generally be differentiated from C. freundii by its ability to decarboxylate ornithine and utilize malonate (5). We have tested 10 C. freundii and 2 Citrobacter diversus clinical isolates, and none were found to express the O157 antigen. Additionally, we tested three American Type Culture Collection (ATCC) strains of C. sedlakii (ATCC 51115, ATCC 51493, and ATCC 51494) and two ATCC strains of C. amalonaticus (ATCC 25405 and ATCC 25406), and all were negative for the O157 antigen. Citrobacter species are normally present in stool and are not considered to be enteric pathogens. To the best of our knowledge, this is the first report of a strain of C. sedlakii which expresses the O157 antigen. This discovery of false-positive results and those previously described by other investigators (1, 8, 9) further emphasize the necessity of additional biochemical and/or toxigenicity testing of isolates when they produce positive reactions with O157 reagents.
